Cardio Diagnostics Holdings, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Cardio Diagnostics Holdings, Inc. (CDIO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $32.64 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $7.11K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $25.53K, a 24.41% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$53.29K, a 514.63% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $102.01K, a 348.85% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $9.78K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$155.55K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$781.50K, a 673.14% decline from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $136.35K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $32.64K 10-Q · filed 2026-08-07 | -$20.65K derived: sum of 3 quarters · filed 2026-08-07 | $81.36K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $25.53K 10-Q · filed 2026-05-15 | -$27.76K derived: sum of 2 quarters · filed 2026-05-15 | $74.25K derived: sum of 3 quarters · filed 2026-05-15 | $14.79K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$53.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $48.72K derived: sum of 2 quarters · filed 2026-03-13 | -$10.74K derived: sum of 3 quarters · filed 2026-08-07 | $9.78K 10-K · filed 2026-03-13 |
| 2025-09-30 | $102.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $42.55K derived: sum of 2 quarters · filed 2026-08-07 | $63.07K 10-Q · filed 2025-11-12 | $75.93K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$59.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$38.94K 10-Q · filed 2026-08-07 | -$26.08K derived: sum of 3 quarters · filed 2026-08-07 | -$3.36K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $20.52K 10-Q · filed 2026-05-15 | $33.37K derived: sum of 2 quarters · filed 2026-05-15 | $56.10K derived: sum of 3 quarters · filed 2026-05-15 | -$116.54K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $12.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $35.58K derived: sum of 2 quarters · filed 2026-03-13 | -$137.06K derived: sum of 3 quarters · filed 2026-03-13 | -$155.55K 10-K · filed 2026-03-13 |
| 2024-09-30 | $22.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$149.91K derived: sum of 2 quarters · filed 2025-11-12 | -$168.41K 10-Q · filed 2025-11-12 | -$548.27K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$172.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$191.13K 10-Q · filed 2025-08-14 | -$570.99K derived: sum of 3 quarters · filed 2025-08-14 | -$599.33K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$18.49K 10-Q · filed 2025-05-15 | -$398.36K derived: sum of 2 quarters · filed 2025-05-15 | -$426.70K derived: sum of 3 quarters · filed 2025-05-15 | -$517.92K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$379.86K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$408.20K derived: sum of 2 quarters · filed 2025-03-20 | -$499.42K derived: sum of 3 quarters · filed 2025-03-20 | -$781.50K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$28.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$119.56K derived: sum of 2 quarters · filed 2024-11-13 | -$401.64K 10-Q · filed 2024-11-13 | -$496.59K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$91.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$373.30K 10-Q · filed 2024-08-12 | -$468.25K derived: sum of 3 quarters · filed 2024-08-12 | -$740.74K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$282.08K 10-Q · filed 2024-05-15 | -$377.03K derived: sum of 2 quarters · filed 2024-05-15 | -$649.52K derived: sum of 3 quarters · filed 2024-05-15 | -$166.93K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$94.96K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$367.44K derived: sum of 2 quarters · filed 2024-04-01 | $115.15K derived: sum of 3 quarters · filed 2024-04-01 | $136.35K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$272.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $210.10K derived: sum of 2 quarters · filed 2023-11-13 | $231.31K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $482.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $503.80K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $21.21K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$5.65K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |